FACULTAD DE ODONTOLOGÍA
Facultad
Institute Catalá Oncología
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institute Catalá Oncología (2)
2020
-
Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
European Journal of Cancer Care, Vol. 29, Núm. 4
2018
-
General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force’s position statement
Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1246-1251